Scribd Logo
Upload

Welcome to Scribd!

  • 35 views

    Introduction To The 2007 Event: London - Chicago - San Diego - Atlanta - Oxford

    Uploaded by

    Rohan Baryah
    The 2007 Biomarkers in Drug Development Conference will address applications of biomarkers in drug discovery and development, with a focus on integrating biomarkers earlier in clinical trials and personalizing treatment approaches. The program will cover topics such as biomarkers for safety assessment, validation methods, challenges in development and implementation, and translating biomarkers between preclinical and clinical research. Industry leaders from pharmaceutical and biotechnology companies will present case studies on cutting-edge biomarker applications from discovery through clinical diagnostics. Attendees will include executives and managers from biomarker, clinical research, and related departments. The conference aims to provide an educational and networking event for 80-100 peers from the global pharmaceutical and biotechnology sectors.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Introduction To The 2007 Event: London - Chicago - San Diego - Atlanta - Oxford

    Uploaded by

    Rohan Baryah
    35 views1 page
    The 2007 Biomarkers in Drug Development Conference will address applications of biomarkers in drug discovery and development, with a focus on integrating biomarkers earlier in clinical trials and personalizing treatment approaches. The program will cover topics such as biomarkers for safety assessment, validation methods, challenges in development and implementation, and translating biomarkers between preclinical and clinical research. Industry leaders from pharmaceutical and biotechnology companies will present case studies on cutting-edge biomarker applications from discovery through clinical diagnostics. Attendees will include executives and managers from biomarker, clinical research, and related departments. The conference aims to provide an educational and networking event for 80-100 peers from the global pharmaceutical and biotechnology sectors.

    Original Description:

    Biomarkers

    Original Title

    Biomarkers

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    The 2007 Biomarkers in Drug Development Conference will address applications of biomarkers in drug discovery and development, with a focus on integrating biomarkers earlier in clinical trials and personalizing treatment approaches. The program will cover topics such as biomarkers for safety assessment, validation methods, challenges in development and implementation, and translating biomarkers between preclinical and clinical research. Industry leaders from pharmaceutical and biotechnology companies will present case studies on cutting-edge biomarker applications from discovery through clinical diagnostics. Attendees will include executives and managers from biomarker, clinical research, and related departments. The conference aims to provide an educational and networking event for 80-100 peers from the global pharmaceutical and biotechnology sectors.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    35 views1 page

    Introduction To The 2007 Event: London - Chicago - San Diego - Atlanta - Oxford

    Uploaded by

    Rohan Baryah
    The 2007 Biomarkers in Drug Development Conference will address applications of biomarkers in drug discovery and development, with a focus on integrating biomarkers earlier in clinical trials and personalizing treatment approaches. The program will cover topics such as biomarkers for safety assessment, validation methods, challenges in development and implementation, and translating biomarkers between preclinical and clinical research. Industry leaders from pharmaceutical and biotechnology companies will present case studies on cutting-edge biomarker applications from discovery through clinical diagnostics. Attendees will include executives and managers from biomarker, clinical research, and related departments. The conference aims to provide an educational and networking event for 80-100 peers from the global pharmaceutical and biotechnology sectors.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 1

    Introduction to the 2007 event

    ACI’s Biomarkers in Drug Development Conference will address the latest applications of biomarkers within drug
    discovery and development, with a key focus on integrating biomarkers earlier in clinical development, and maximising
    their use as part of a personalised approach to treatment.

    The programme will focus on key topics Among the speakers:


    including:
    • Dr. Andrew Lockhart, CPDM-Neurology
    Biomarker Group, GlaxoSmithKline
    • Biomarkers in early safety and toxicity assessment • Dr. Ann Kapoun, Associate Director, Biomarker
    • Biomarkers as validation tools – determining R&D, Clinical Pharmacology & Experimental
    validation parameters Medicine, ALZA
    • Challenges in development and implementation of • Dr. Eric Blomme, Project Leader, Cell and
    biomarkers Molecular Toxicology, Abbott Laboratories
    • Integrating biomarkers earlier – using markers in • Dr. Brian Swanson, US Head of Biomarkers,
    early clinical development Clinical and Experimental Pharmacology, Sanofi-
    • Translational biomarkers – bridging the gap Aventis
    • Biomarkers as in vitro diagnostics • Dr. Yixin Wang, Group Director, Discovery
    Research and Pharmaceutical Biomarker Support,
    Veridex and Ortho-Clinical Diagnostics, Johnson &
    Johnson

    Our expert panel of speakers comprises leading executives and senior researchers from pharmaceutical and
    biotechnology companies. Through case study-driven presentations, our speakers will provide an insight into
    cutting-edge applications and developments in the use of biomarkers from discovery through to clinical
    diagnostics, tackling issues from validation to safety and toxicity.

    Who will attend?

    Attendees will be drawn from pharmaceutical and biotechnology companies and include VPs, Directors and Managers of:
    Biomarkers, Translational/Experimental Medicine, Clinical Research/Development, Pharmacology, Toxicology and Safety
    Assessment, Clinical PK/PD, Discovery Medicine, Molecular Medicine/Diagnostics

    How to attend?

    We strictly limit the number of participants at the conference. That means that 80 to 100 peers from the global
    pharmaceutical and biotechnology industry will be attending the event to learn from the educational elements and with
    plenty of time to network with this targeted group.

    We simply advised a quick registration to make sure to not miss out on the opportunity. To register or to get additional
    information please contact Melanie Mulazzi of ACI on +44 207 368 1654 or [email protected].

    About ACI

    ACI, a UK owned company, have been running successful conferences for the last 8 years in the USA. Headquartered in
    Chicago with offices all around the States, they run forums in varied fields and are market leaders in Healthcare business
    conferences. Opening their European head office at the end of 2005, they have expanded rapidly and are launching a
    series of events covering emerging markets, the maritime industry and now the pharmaceutical industry.
    * Please note that speakers and topics are liable to change *

    London • Chicago • San Diego • Atlanta • Oxford


    Active Communications Europe Ltd, 58-60 Kensington Church Street London, W8 4DB, United Kingdom
    Tel: 0 (+44) 20 7368 1654 • Fax: 0 (+44) 20 7368 3365 • www.acius.net • Reg. in UK 5620385

    You might also like